Surgical Outcomes of Subtotal Parathyroidectomy for Renal Hyperparathyroidism
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Min Song | - |
dc.contributor.author | Kim, Gheun-Ho | - |
dc.contributor.author | Lee, Chang Hwa | - |
dc.contributor.author | Park, Joon-Sung | - |
dc.contributor.author | Lee, Ji Young | - |
dc.contributor.author | Tae, Kyung | - |
dc.date.accessioned | 2021-08-02T09:27:53Z | - |
dc.date.available | 2021-08-02T09:27:53Z | - |
dc.date.created | 2021-05-12 | - |
dc.date.issued | 2020-05 | - |
dc.identifier.issn | 1976-8710 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/9837 | - |
dc.description.abstract | Objectives The aim of this study was to evaluate the effectiveness of subtotal parathyroidectomy for patients with renal hyperparathyroidism. Methods We studied 25 patients with renal hyperparathyroidism who underwent subtotal parathyroidectomy from October 2002 to October 2017. We analyzed serum intact parathyroid hormone (iPTH), calcium, and inorganic phosphorus levels before and at multiple time points following surgery, and evaluated the surgical outcomes and complications. Results Of the 25 patients, 13 (52%) were male and 12 (48%) were female, and the mean age was 53.4±9.3 years. The mean duration of dialysis before parathyroidectomy was 156.8±79.5 months. Mean preoperative serum iPTH and calcium levels were 1,199.0±571.3 pg/mL and 10.5±1.0 mg/dL, respectively. At 6 months postoperatively, the mean iPTH and calcium levels decreased to 49.2±47.6 pg/mL (P<0.01) and 8.0±1.0 mg/dL (P<0.01), respectively. Recurrent hyperparathyroidism occurred in two patients: one subsequently underwent kidney transplantation and the other continued hemodialysis and maintained normal calcium levels. One patient developed postoperative permanent hypoparathyroidism. Conclusion Subtotal parathyroidectomy is a safe and effective surgical treatment for renal hyperparathyroidism. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | KOREAN SOC OTORHINOLARYNGOL | - |
dc.title | Surgical Outcomes of Subtotal Parathyroidectomy for Renal Hyperparathyroidism | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Gheun-Ho | - |
dc.contributor.affiliatedAuthor | Lee, Chang Hwa | - |
dc.contributor.affiliatedAuthor | Park, Joon-Sung | - |
dc.contributor.affiliatedAuthor | Lee, Ji Young | - |
dc.contributor.affiliatedAuthor | Tae, Kyung | - |
dc.identifier.doi | 10.21053/ceo.2019.01340 | - |
dc.identifier.wosid | 000532404100015 | - |
dc.identifier.bibliographicCitation | CLINICAL AND EXPERIMENTAL OTORHINOLARYNGOLOGY, v.13, no.2, pp.173 - 178 | - |
dc.relation.isPartOf | CLINICAL AND EXPERIMENTAL OTORHINOLARYNGOLOGY | - |
dc.citation.title | CLINICAL AND EXPERIMENTAL OTORHINOLARYNGOLOGY | - |
dc.citation.volume | 13 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 173 | - |
dc.citation.endPage | 178 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002588363 | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Otorhinolaryngology | - |
dc.relation.journalWebOfScienceCategory | Otorhinolaryngology | - |
dc.subject.keywordPlus | SECONDARY HYPERPARATHYROIDISM | - |
dc.subject.keywordPlus | KIDNEY-DISEASE | - |
dc.subject.keywordPlus | MANAGEMENT | - |
dc.subject.keywordAuthor | Secondary Hyperparathyroidism | - |
dc.subject.keywordAuthor | Chronic Renal Insufficiency | - |
dc.subject.keywordAuthor | Parathyroidectomy | - |
dc.identifier.url | https://www.e-ceo.org/journal/view.php?doi=10.21053/ceo.2019.01340 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.